Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$7,618,779
+$1,215,341 QoQ
Shares Held
6,352
-8.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.49%
of 13F equity value
Holder Rank
#1,419
of 4,605 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AssuredPartners Investment Advisors, LLC holds $25,676,613 across 8 Drug Manufacturers - General names. LLY ranks #1 (29.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
6,352 | $7,618,779 | |
| 2 | ABBV |
AbbVie Inc.
|
25,321 | $6,371,776 | |
| 3 | JNJ |
Johnson & Johnson
|
17,251 | $4,381,236 | |
| 4 | AMGN |
Amgen Inc
|
10,651 | $3,856,940 | |
| 5 | PFE |
Pfizer Inc
|
77,949 | $1,877,011 | |
| 6 | MRK |
Merck & Co., Inc.
|
8,218 | $1,056,013 | |
| 7 | SNY |
Sanofi
|
6,382 | $272,256 | |
| 8 | NVS |
Novartis AG
|
1,548 | $242,602 |
All Filings in LLY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,618,779 | 6,352 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $6,403,438 | 6,962 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $2,271,873 | 2,114 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $1,587,040 | 2,080 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $1,631,556 | 2,093 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $1,902,070 | 2,303 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,582,600 | 2,050 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||